[1]
A. Valverde Legarda and M. C. Berrouet, “Cardiovascular toxic manifestations with the use of antimonials in a patient with cutaneous leishmaniasis ”, Med UPB, vol. 38, no. 1, pp. 78–84, Jun. 2019, doi: 10.18566/medupb.v38n1.a10.